Abstract | BACKGROUND: METHODS: This was a cross-sectional study of Rwandan acute care surgery patients with infection. Samples were processed for culture and susceptibility patterns using Kirby-Bauer disk diffusion method. Third-generation cephalosporin resistance and ESBL-PE were compared in patients with CAI versus HAI. RESULTS: Over 14 months, 220 samples were collected from 191 patients: 116 (62%) patients had CAI, 59 (32%) had HAI, and 12 (6%) had both CAI and HAI. Most (n = 178, 94%) patients were started on antibiotics with third-generation cephalosporins ( ceftriaxone n = 109, 57%; cefotaxime n = 52, 27%) and metronidazole (n = 155, 81%) commonly given. Commonly isolated organisms included Escherichia coli (n = 62, 42%), Staphylococcus aureus (n = 27, 18%), and Klebsiella spp. (n = 22, 15%). Overall, 67 of 113 isolates tested had resistance to third-generation cephalosporins, with higher resistance seen in HAI compared with CAI (74% vs 46%, p value = 0.002). Overall, 47 of 89 (53%) isolates were ESBL-PE with higher rates in HAI compared with CAI (73% vs 38%, p value = 0.001). CONCLUSIONS: There is broad and prolonged use of third-generation cephalosporins despite high resistance rates. ESBL-PE are high in Rwandan surgical patients with higher rates in HAI compared with CAIs. Infection prevention practices and antibiotic stewardship are critical to reduce infection rates with resistant organisms in a low-resource setting.
|
Authors | Vital Muvunyi, Christophe Mpirimbanyi, Jean Bosco Katabogama, Thierry Cyuzuzo, Theoneste Nkubana, Jean Baptiste Mugema, Emile Musoni, Christian Urimubabo, Jennifer Rickard |
Journal | World journal of surgery
(World J Surg)
Vol. 44
Issue 10
Pg. 3290-3298
(10 2020)
ISSN: 1432-2323 [Electronic] United States |
PMID | 32535645
(Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural)
|
Topics |
- Adult
- Community-Acquired Infections
(drug therapy, prevention & control)
- Cross Infection
(drug therapy, prevention & control)
- Cross-Sectional Studies
- Drug Resistance, Bacterial
- Enterobacteriaceae Infections
(drug therapy, prevention & control)
- Escherichia coli
(isolation & purification)
- Female
- Humans
- Male
- Middle Aged
- Staphylococcus aureus
(isolation & purification)
- Tertiary Care Centers
|